BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
7/21/17 Bayer (BAYRY) BAY 94-9343 for Mesothelioma Subscribers Only Subscribers Only Subscribers Only
7/21/17 UCB (UCB:BB) Bimekizumab for Psoriasis Subscribers Only Subscribers Only Subscribers Only
7/21/17 GlaxoSmithKline (GSK) Benlysta SC for Systemic Lupus Erythematosus (SLE) Subscribers Only Subscribers Only Subscribers Only
7/21/17 Roche (RHHBF) Emicizumab for Hemophilia A Subscribers Only Subscribers Only Subscribers Only
7/20/17 Ironwood (IRWD) IW-3718 for Gastroesophageal Reflux Disease (GERD) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
07/21/17 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
07/21/17 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
07/21/17 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
Now - 07/24/17 Subscribers Only Subscribers Only Regulatory - Approval Decision (Europe)
Now - 07/24/17 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)